Azalea Biotec Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.21 M
- Company Age 15 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 2.16%
- Profit Growth -719.63%
- Ebitda 69.20%
- Net Worth -15.43%
- Total Assets 0.85%
About Azalea Biotec
Azalea Biotec Private Limited (ABPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 May 2009 and has a history of 15 years and eight months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.21 M, as per Ministry of Corporate Affairs (MCA) records.
Vishal Durgade, Avinash Khatave, and Arun Kore serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24100MH2009PTC192323
-
Company No.
192323
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 May 2009
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Azalea Biotec?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Vishal Durgade | Director | 12-May-2009 | Current |
Avinash Khatave | Director | 12-May-2009 | Current |
Arun Kore | Director | 12-May-2009 | Current |
Financial Performance of Azalea Biotec.
Azalea Biotec Private Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 2.16% increase. The company also saw a substantial fall in profitability, with a 719.63% decrease in profit. The company's net worth observed a substantial decline by a decrease of 15.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Azalea Biotec?
Unlock access to Azalea Biotec's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Azalea Biotec?
Azalea Biotec has a workforce of 12 employees as of Dec 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Azalea Biotec, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Azalea Biotec's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.